ALDX NASDAQ
Aldeyra The
1W: -3.3%
1M: -21.5%
3M: -48.7%
YTD: -75.0%
1Y: -77.7%
3Y: -80.8%
5Y: -86.2%
$1.17
-0.12 (-9.30%)
Weekly Expected Move ±13.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-04-29
Earliest Filing
2024-11-18
Latest Filing
partner: 4
Counterparties (Filed by ALDX)
4 relationshipsCompanies named in ALDX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| AbbVie Inc. | ABBV | partner | Partner in an Exclusive Option Agreement amended by an Extension Side Letter regarding launch activities and expense rei | 2024-11-18 | View |
| AbbVie Inc. | ABBV | partner | Entered into an exclusive option agreement for co-development and co-commercialization of reproxalap in the US and licen | 2023-11-01 | View |
| Jefferies LLC | JEF | partner | Served as underwriter representative in the public offering of Aldeyra Therapeutics, Inc. common stock. | 2021-04-29 | View |
| SVB Leerink LLC | — | partner | Served as underwriter representative in the public offering of Aldeyra Therapeutics, Inc. common stock. | 2021-04-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-30 | Material Agreement; Exhibits | Agreement | View |
| 2026-07-15 | Other Events | View | |
| 2026-06-10 | Officer/Director Change; Shareholder Vote; Regulation FD; Exhibits | View | |
| 2026-05-01 | Regulation FD; Exhibits | View | |
| 2026-04-20 | Officer/Director Change | View | |
| 2026-04-01 | Other Events | View | |
| 2026-03-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-31 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-16 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-28 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-19 | Financial Statements and Exhibits | View | |
| 2025-07-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-26 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-11 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-06 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR